These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36870568)

  • 1. Serum Proteomics Identifies Biomarkers Associated With the Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Wang L; Zhu M; Li Y; Yan P; Li Z; Chen X; Yang J; Pan X; Zhao H; Wang S; Yuan H; Zhao M; Sun X; Wan R; Li F; Wang X; Yu H; Rosas I; Ding C; Yu G
    Mol Cell Proteomics; 2023 Apr; 22(4):100524. PubMed ID: 36870568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
    Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
    Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.
    Saraswat M; Joenväärä S; Tohmola T; Sutinen E; Vartiainen V; Koli K; Myllärniemi M; Renkonen R
    Sci Rep; 2020 May; 10(1):7787. PubMed ID: 32385381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis.
    Niu R; Liu Y; Zhang Y; Zhang Y; Wang H; Wang Y; Wang W; Li X
    PLoS One; 2017; 12(1):e0170741. PubMed ID: 28122020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
    Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
    Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.
    Rindlisbacher B; Schmid C; Geiser T; Bovet C; Funke-Chambour M
    Respir Res; 2018 Jan; 19(1):7. PubMed ID: 29321022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
    Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.
    Maher TM
    Eur Respir Rev; 2013 Jun; 22(128):148-52. PubMed ID: 23728868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid metabolism-related genes in bronchoalveolar lavage fluid unveil prognostic and immune infiltration in idiopathic pulmonary fibrosis.
    Lyu Y; Guo C; Zhang H
    Front Endocrinol (Lausanne); 2022; 13():1001563. PubMed ID: 36267568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of cellular senescence in idiopathic pulmonary fibrosis.
    Aversa Z; Atkinson EJ; Carmona EM; White TA; Heeren AA; Jachim SK; Zhang X; Cummings SR; Chiarella SE; Limper AH; LeBrasseur NK
    Respir Res; 2023 Apr; 24(1):101. PubMed ID: 37029417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study.
    Bergantini L; d'Alessandro M; Cameli P; Carleo A; Landi C; Vietri L; Lanzarone N; Pieroni M; Sestini P; Bargagli E
    Intern Med J; 2021 May; 51(5):705-711. PubMed ID: 32040256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis.
    Carleo A; Bargagli E; Landi C; Bennett D; Bianchi L; Gagliardi A; Carnemolla C; Perari MG; Cillis G; Armini A; Bini L; Rottoli P
    J Breath Res; 2016 Apr; 10(2):026007. PubMed ID: 27082636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker signatures for progressive idiopathic pulmonary fibrosis.
    Clynick B; Corte TJ; Jo HE; Stewart I; Glaspole IN; Grainge C; Maher TM; Navaratnam V; Hubbard R; Hopkins PMA; Reynolds PN; Chapman S; Zappala C; Keir GJ; Cooper WA; Mahar AM; Ellis S; Goh NS; De Jong E; Cha L; Tan DBA; Leigh L; Oldmeadow C; Walters EH; Jenkins RG; Moodley Y
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34675050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
    Wang Y; Yella J; Chen J; McCormack FX; Madala SK; Jegga AG
    BMC Pulm Med; 2017 Oct; 17(1):133. PubMed ID: 29058630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in idiopathic pulmonary fibrosis: the quest for biomarkers.
    Khan T; Dasgupta S; Ghosh N; Chaudhury K
    Mol Omics; 2021 Feb; 17(1):43-58. PubMed ID: 33073811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.
    Ashley SL; Xia M; Murray S; O'Dwyer DN; Grant E; White ES; Flaherty KR; Martinez FJ; Moore BB
    PLoS One; 2016; 11(8):e0159878. PubMed ID: 27490795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.